A Phase 3, Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy Safety and Tolerability of Albumin....... Grant uri icon

total award amount

  • 176093.38

direct costs

  • 140874.30

sponsor award ID

  • HGS1008-C1060 US-043
  • HGS1008-C1060US-043

local award ID

  • 00063131